Strategy
MSTR
MARA Holdings
MARA
英伟达
NVDA
特斯拉
TSLA
Coinbase
COIN
美股市场个股详情
ASND Ascendis Pharma A/S
- 156.580
- +3.440+2.25%
收盘价 02/28 16:00 (美东)
- 156.580
- 0.0000.00%
盘后 20:01 (美东)
93.70亿总市值-23.11市盈率TTM
157.490最高价153.000最低价42.94万股成交量153.000今开153.140昨收6708.08万成交额0.72%换手率亏损市盈率(静)5984.36万总股本157.49052周最高-85.42市净率92.97亿流通值111.09052周最低--股息TTM5937.26万流通股183.980历史最高--股息率TTM2.93%振幅11.920历史最低156.209平均价1股每手
关于Ascendis Pharma A/S公司
Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。该公司的产品线包括内分泌学和肿瘤学，其中包括TransCon PTH， TransCon CNP等。该公司在北美、欧洲和世界其他地区开展业务，其大部分收入来自北美。
公司介绍
公司代码ASND
公司名称Ascendis Pharma A/S
上市日期2015/01/28
发行价格18.00
成立日期2006
CEOMr. Jan Moller Mikkelsen
所属市场纳斯达克
员工数量1017
证券类型存托凭证
ADS转换比例1.0 : 1.0
年结日12-31
公司地址Tuborg Boulevard 12
城市Hellerup
省份首都地区
国家丹麦
邮编2900
电话45-70-22-22-44
董事高管
- 姓名
- 职务
- 年薪
- Jan Moller Mikkelsen
- President, Chief Executive Officer and Director
- --
- Michael Wolff Jensen
- Executive Vice President and Chief Legal Officer
- --
- Lotte Sonderbjerg
- Executive Vice President and Chief Administrative Officer
- --
- Aimee Shu
- Executive Vice President and Chief Medical Officer
- --
- Scott T Smith
- Executive Vice President and Chief Financial Officer
- --
- Mads Bodenhoff
- Senior Vice President, Head of Finance and Principal Accounting Officer
- --
- Flemming Steen Jensen
- Executive Vice President, Product Supply and Quality
- --
- Dr. Kennett Sprogoe, PhD
- Executive Vice President and Head of Innovation and Research
- --
- Jay Donovan Wu
- Executive Vice President and U.S. President
- --
- Dr. Stina Singel, M.D.
- Executive Vice President and Head of Clinical Development, Oncology
- --
- Dr. Albert Cha, M.D.,PhD
- Chairman of the Board
- --
- Lisa Bright
- Independent Director
- --
- Siham Imani
- Independent Director
- --
- William Carl Fairey, Jr
- Independent Director
- --
- Lars Holtug
- Independent Director
- --